Gayatri BioOrganics Ltd

Gayatri BioOrganics Limited, a micro-cap commodity chemicals company with a market capitalisation of ₹106.00 crores, reported another quarter of complete operational shutdown in Q3 FY26 (October-December 2025), posting zero revenue and a net loss of ₹0.22 crores. The company's stock, trading at ₹14.28, remains trapped in a prolonged crisis that has seen no commercial activity for over seven consecutive quarters, raising serious questions about its viability as a going concern.

Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Gayatri BioOrganics Ltd, a key player in the Commodity Chemicals sector, reached a significant milestone today by hitting a new 52-week high of Rs.19.99. This achievement marks a remarkable rally for the stock, reflecting strong momentum over the past year despite a slight pullback in today’s session.

Gayatri BioOrganics Ltd has reached a significant milestone by hitting a new 52-week high of Rs.19.59, marking a notable surge in its stock price amid a sustained rally over the past several trading sessions.

Gayatri BioOrganics, a key player in the Commodity Chemicals sector, reached a significant milestone today by touching a new 52-week high of Rs.18.66. This achievement reflects sustained momentum in the stock, which has been on a steady upward trajectory over the past week.

Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with an up-to-date view of its fundamentals, returns, and market standing.

Gayatri BioOrganics, a key player in the commodity chemicals sector, has reached a significant milestone by touching a new 52-week high of Rs.18.1 today, reflecting sustained momentum in its stock performance over recent sessions.

Gayatri BioOrganics, a key player in the commodity chemicals sector, reached a fresh 52-week high of Rs.17.33 today, marking a significant milestone in its market performance. This new peak reflects sustained momentum driven by consistent gains over the past week and trading above all major moving averages.

Gayatri BioOrganics, a key player in the Commodity Chemicals sector, has reached a significant milestone by touching a new 52-week high of Rs.16.29. This achievement reflects sustained momentum in the stock, supported by a series of gains over recent sessions and favourable market conditions.

Gayatri BioOrganics, a key player in the Commodity Chemicals sector, reached a fresh 52-week high of Rs.15.75 today, marking a significant milestone in its stock performance amid a broadly positive market environment.

Gayatri BioOrganics, a key player in the Commodity Chemicals sector, reached a new 52-week high of Rs.15.74 today, reflecting a remarkable performance over the past year and underscoring the stock’s strong momentum amid broader market fluctuations.

Gayatri BioOrganics, a key player in the Commodity Chemicals sector, reached a fresh 52-week high of Rs.15.2 today, reflecting a notable phase of momentum and sustained gains over recent sessions.

Gayatri BioOrganics has reached a significant milestone by touching a new 52-week high of Rs.14.35, reflecting a strong momentum in the commodity chemicals sector. The stock's recent performance highlights a notable rally driven by sustained gains over the past several sessions.

Gayatri BioOrga., a microcap player in the Commodity Chemicals sector, has recently undergone a revision in its market evaluation metrics. This shift reflects nuanced changes across several key analytical parameters, including quality, valuation, financial trends, and technical outlook, providing investors with a refreshed perspective on the stock’s current standing.